Fallopia japonica, a Natural Modulator, Can Overcome Multidrug Resistance in Cancer Cells

Evidence-based Complementary and Alternative Medicine : ECAM
Safaa Yehia EidMichael Wink

Abstract

Resistance of cancer cells to chemotherapy is controlled by the decrease of intracellular drug accumulation, increase of detoxification, and diminished propensity of cancer cells to undergo apoptosis. ATP-binding cassette (ABC) membrane transporters with intracellular metabolic enzymes contribute to the complex and unresolved phenomenon of multidrug resistance (MDR). Natural products as alternative medicine have great potential to discover new MDR inhibitors with diverse modes of action. In this study, we characterized several extracts of traditional Chinese medicine (TCM) plants (N = 16) for their interaction with ABC transporters, cytochrome P3A4 (CYP3A4), and glutathione-S-transferase (GST) activities and their cytotoxic effect on different cancer cell lines. Fallopia japonica (FJ) (Polygonaceae) shows potent inhibitory effect on CYP3A4 P-glycoprotein activity about 1.8-fold when compared to verapamil as positive control. FJ shows significant inhibitory effect (39.81%) compared with the known inhibitor ketoconazole and 100 μg/mL inhibited GST activity to 14 μmol/min/mL. FJ shows moderate cytotoxicity in human Caco-2, HepG-2, and HeLa cell lines; IC50 values were 630.98, 198.80, and 317.37 µg/mL, respectively. LC-ESI-MS were ...Continue Reading

References

Aug 1, 1989·Chemical & Pharmaceutical Bulletin·T KuboM Takido
Oct 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·W H HabigW B Jakoby
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P R TwentymanS Rayner
May 20, 1999·Annual Review of Pharmacology and Toxicology·F P Guengerich
Mar 18, 2000·Toxicology Letters·R C StrangeA A Fryer
Feb 24, 2001·Chemical & Pharmaceutical Bulletin·E OkuyamaM Yamazaki
Mar 22, 2001·Advanced Drug Delivery Reviews·R K Jain
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·A PluenR K Jain
Jul 25, 2006·Expert Opinion on Drug Metabolism & Toxicology·James J CaliDavid Liu
Feb 21, 2007·Journal of Natural Products·David J Newman, Gordon M Cragg
Apr 25, 2007·Cancer Treatment Reviews·S HarmsenJ H M Schellens
Jul 13, 2007·Phytochemical Analysis : PCA·Tao YiZongwei Cai
Jun 12, 2008·Journal of the National Cancer Institute·Vicki Brower
Dec 11, 2008·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Monika BhadauriaSangeeta Shukla
May 12, 2009·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Stefania NobiliSergio Capaccioli
Jul 11, 2009·Science·Jesse W-H Li, John C Vederas
Jul 14, 2009·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Heng JiangHoujie Liang
Jan 1, 2012·Metabolites·Daniel A DiasUte Roessner
Nov 8, 2014·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Charles AwortweBernd Rosenkranz
Feb 5, 2015·Nutrition and Cancer·Aysegul Cort, Tomris Ozben
Mar 18, 2015·Biochemistry·Ilia G DenisovStephen G Sligar

❮ Previous
Next ❯

Methods Mentioned

BETA
environmental stress
PCR
light microscopy
Assay

Software Mentioned

MEGA
BioEdit

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis